Quarterly report pursuant to Section 13 or 15(d)

DERIVATIVE FINANCIAL INSTRUMENTS AND WARRANT LIABILITIES (Details Narrative)

v3.24.1.u1
DERIVATIVE FINANCIAL INSTRUMENTS AND WARRANT LIABILITIES (Details Narrative) - USD ($)
3 Months Ended
Nov. 17, 2023
Mar. 31, 2024
Dec. 31, 2023
Mar. 31, 2023
Derivative Instruments, Gain (Loss) [Line Items]        
Gain on exercise of series B warrants   $ 165,355   $ 0
Series A And B Warrants [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Stock issuance costs     $ 1,451,249  
Series A Warrants [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Gross proceeds from issuance of equity $ 10,990,530      
Series B Warrants [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Gross proceeds from issuance of equity $ 3,345,961      
May 2023 Warrants [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Gain on fair value of conversion features   $ 5,107,794